![](/img/cover-not-exists.png)
Lesion remyelinating activity of GSK239512 versus placebo in patients with relapsing-remitting multiple sclerosis: a randomised, single-blind, phase II study
Schwartzbach, Caryl J., Grove, Richard A., Brown, Robert, Tompson, Debra, Then Bergh, Florian, Arnold, Douglas L.Volume:
264
Language:
english
Journal:
Journal of Neurology
DOI:
10.1007/s00415-016-8341-7
Date:
February, 2017
File:
PDF, 534 KB
english, 2017